Xiaoming Feng

机构：Tianjin University of Technology, Hangzhou Normal University, Chinese Academy of Medical Sciences & Peking Union Medical College, Henan Provincial People's Hospital, Institute of Hematology & Blood Diseases Hospital, Anyang Hospital of Traditional Chinese Medicine, Wuhan University of Science and Technology · ORCID：0000-0002-2855-5871

发表论文 135 篇 · 总被引 3880 次 · h-index 31

代表论文

• Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia (2023 · Journal of Hematology & Oncology · 被引 89)
• Macrophages originated IL-33/ST2 inhibits ferroptosis in endometriosis via the ATF3/SLC7A11 axis (2023 · Cell Death and Disease · 被引 82)
• Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study (2023 · The Lancet Oncology · 被引 70)
• Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial (2024 · Nature Medicine · 被引 48)
• C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial (2024 · Nature Communications · 被引 40)
• Exosomal secreted SCIMP regulates communication between macrophages and neutrophils in pneumonia (2024 · Nature Communications · 被引 20)